Edwards Lifesciences Corp
EW
Company Profile
Business description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Contact
One Edwards Way
IrvineCA92614
USAT: +1 949 250-2500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
19,800
Edwards Lifesciences Corp News & Analysis
personal-finance
US stock market outlook: tariffs are 2025's wild card
Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,599.40 | 56.50 | 0.66% |
| CAC 40 | 7,489.35 | 43.66 | 0.59% |
| DAX 40 | 20,340.57 | 124.38 | 0.62% |
| Dow JONES (US) | 42,528.36 | 178.20 | -0.42% |
| FTSE 100 | 8,245.28 | 4.38 | -0.05% |
| HKSE | 19,273.93 | 173.65 | -0.89% |
| NASDAQ | 19,489.68 | 375.30 | -1.89% |
| Nikkei 225 | 40,001.51 | 81.79 | -0.20% |
| NZX 50 Index | 13,043.11 | 1.05 | 0.01% |
| S&P 500 | 5,909.03 | 66.35 | -1.11% |
| S&P/ASX 200 | 8,349.10 | 64.00 | 0.77% |
| SSE Composite Index | 3,236.68 | 7.03 | 0.22% |